| Item Type | Name |
|
Concept
|
Escherichia coli Infections
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Drug Resistance, Viral
|
|
Concept
|
Interleukin-10
|
|
Concept
|
Cyclin D1
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Dideoxynucleosides
|
|
Concept
|
Incidence
|
|
Concept
|
Staphylococcal Infections
|
|
Concept
|
Continuity of Patient Care
|
|
Concept
|
Enterocolitis, Pseudomembranous
|
|
Concept
|
Sex Distribution
|
|
Concept
|
Gene Expression
|
|
Concept
|
HIV Integrase Inhibitors
|
|
Concept
|
Retinoblastoma Protein
|
|
Concept
|
Disease Progression
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Mycobacterium Infections, Nontuberculous
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Cyclin B
|
|
Concept
|
Cyclin B1
|
|
Concept
|
HIV-1
|
|
Concept
|
Administration, Oral
|
|
Concept
|
China
|
|
Concept
|
Confidence Intervals
|
|
Concept
|
Nontuberculous Mycobacteria
|
|
Concept
|
Georgia
|
|
Concept
|
Disease Susceptibility
|
|
Concept
|
Dendritic Cells
|
|
Concept
|
Algorithms
|
|
Concept
|
Immunophenotyping
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Seasons
|
|
Concept
|
CD4 Lymphocyte Count
|
|
Concept
|
Rifampin
|
|
Concept
|
Nucleolus Organizer Region
|
|
Concept
|
Legionella pneumophila
|
|
Concept
|
Acute Disease
|
|
Concept
|
Antibodies, Viral
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
Expectorants
|
|
Concept
|
B7-1 Antigen
|
|
Concept
|
Diabetes Mellitus
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Area Under Curve
|
|
Concept
|
Cerebrovascular Disorders
|
|
Concept
|
Delayed Diagnosis
|
|
Concept
|
HIV Infections
|
|
Concept
|
Anti-HIV Agents
|
|
Concept
|
Lectins, C-Type
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Medicaid
|
|
Concept
|
Cells, Cultured
|
|
Concept
|
Disease Notification
|
|
Concept
|
Pseudomonas Infections
|
|
Concept
|
Drug Resistance, Multiple, Bacterial
|
|
Concept
|
Viral Load
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Zidovudine
|
|
Concept
|
Escherichia coli
|
|
Concept
|
Hospitals
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Hospitals, Community
|
|
Concept
|
Ambulatory Care Facilities
|
|
Concept
|
Bacteremia
|
|
Concept
|
Quality-Adjusted Life Years
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Delayed-Action Preparations
|
|
Concept
|
Antimalarials
|
|
Concept
|
Enterobacteriaceae Infections
|
|
Concept
|
Cost-Benefit Analysis
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
AIDS Serodiagnosis
|
|
Concept
|
Lamivudine
|
|
Concept
|
Pseudomonas aeruginosa
|
|
Concept
|
Legionnaires' Disease
|
|
Concept
|
Salmonella Infections
|
|
Concept
|
Enterobacteriaceae
|
|
Concept
|
Prevalence
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Microbial Sensitivity Tests
|
|
Concept
|
Health Status Disparities
|
|
Concept
|
Drug Resistance, Multiple, Viral
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
PPAR gamma
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Gram-Negative Bacterial Infections
|
|
Concept
|
Drug Resistance, Bacterial
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Residence Characteristics
|
|
Concept
|
Patient Isolation
|
|
Concept
|
Cell Line
|
|
Concept
|
Hepatitis B
|
|
Concept
|
HIV Protease Inhibitors
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
Cholesterol
|
|
Concept
|
Adenylate Kinase
|
|
Concept
|
Risk Factors
|
|
Concept
|
Emigration and Immigration
|
|
Concept
|
beta-Lactamases
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
HIV
|
|
Concept
|
Comorbidity
|
|
Concept
|
HIV Core Protein p24
|
|
Concept
|
Diagnostic Errors
|
|
Concept
|
Age Distribution
|
|
Academic Article
|
Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients.
|
|
Academic Article
|
Imported malaria at an inner-city hospital in the United States.
|
|
Academic Article
|
Epidemiological characterization of individuals with newly reported HIV infection: South Carolina, 2004-2005.
|
|
Academic Article
|
CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection.
|
|
Academic Article
|
Report from the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. When to start HIV treatment in infants.
|
|
Academic Article
|
Report from the 15th Retrovirus Conference. Durability of new agents for treatment-experienced patients.
|
|
Academic Article
|
Risk-based HIV testing in South Carolina health care settings failed to identify the majority of infected individuals.
|
|
Academic Article
|
HIV and community-acquired MRSA.
|
|
Academic Article
|
Report from the 16th Conference on Retroviruses and Opportunistic Infections. SWITCHMRK: an avoidable raltegravir disaster.
|
|
Academic Article
|
Serial knife stabbings with HIV exposure--implications for post-exposure prophylaxis.
|
|
Academic Article
|
Missed opportunities for early HIV diagnosis in correctional facilities.
|
|
Academic Article
|
Report from the 5th IAS Conference on HIV Pathogenesis Treatment and Prevention. ALTAIR--the end of NRTI-only regimes.
|
|
Academic Article
|
Report from the 17th Conference on Retroviruses and Opportunistic Infections. CCR5 antagonists--out with the old, in with the new?
|
|
Academic Article
|
Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner.
|
|
Academic Article
|
Raltegravir--beauty and the beast. Both the advantages and the limitations of this integrase inhibitor were evident this year.
|
|
Academic Article
|
HIV drug pipeline promises more fixed-dose combinations. By 2011, providers and patients may be able to choose between several "one pill, once-daily" options.
|
|
Academic Article
|
Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
|
|
Academic Article
|
Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia.
|
|
Academic Article
|
Barriers to care and service needs among chronically homeless persons in a housing first program.
|
|
Academic Article
|
Rare case of rilpivirine-induced severe allergic hepatitis.
|
|
Academic Article
|
Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms.
|
|
Academic Article
|
Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011.
|
|
Academic Article
|
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.
|
|
Academic Article
|
Clostridium difficile: case report and concise review of fecal microbiota transplantation.
|
|
Academic Article
|
Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults.
|
|
Academic Article
|
Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis.
|
|
Academic Article
|
Disparities in viral load and CD4 count trends among HIV-infected adults in South Carolina.
|
|
Academic Article
|
Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review.
|
|
Academic Article
|
Rural-urban differences in HIV viral loads and progression to AIDS among new HIV cases.
|
|
Academic Article
|
Sexual Orientation and Risk.
|
|
Academic Article
|
Rilpivirine arrives--with caveats.
|
|
Academic Article
|
NRTI-sparing regimens continue to disappoint.
|
|
Academic Article
|
The South Carolina HIV Cascade of Care.
|
|
Academic Article
|
Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.
|
|
Academic Article
|
HIV community viral load trends in South Carolina.
|
|
Academic Article
|
Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae.
|
|
Academic Article
|
Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections.
|
|
Academic Article
|
New HCV treatment paradigms--now also for patients with HIV.
|
|
Academic Article
|
Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa.
|
|
Academic Article
|
Non-tuberculous mycobacterial bloodstream infections in patients with indwelling vascular catheters - the role of sickle cell anaemia.
|
|
Academic Article
|
The South Carolina rural-urban HIV continuum of care.
|
|
Academic Article
|
Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis.
|
|
Academic Article
|
Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
|
|
Academic Article
|
Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections.
|
|
Academic Article
|
The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.
|
|
Academic Article
|
Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections.
|
|
Academic Article
|
Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis.
|
|
Academic Article
|
Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence.
|
|
Academic Article
|
Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions.
|
|
Academic Article
|
Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection.
|
|
Academic Article
|
Cost-Effectiveness Analysis of Early vs Late Diagnosis of HIV-Infected Patients in South Carolina.
|
|
Academic Article
|
Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates.
|
|
Academic Article
|
Spike Protein of SARS-CoV-2 Activates Macrophages and Contributes to Induction of Acute Lung Inflammations in Mice.
|
|
Academic Article
|
Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing.
|
|
Academic Article
|
Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
|
|
Academic Article
|
Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2?
|
|
Concept
|
Click Chemistry
|
|
Concept
|
Single-Cell Analysis
|
|
Concept
|
Transcriptome
|
|
Concept
|
Coinfection
|
|
Concept
|
Inappropriate Prescribing
|
|
Concept
|
Pandemics
|
|
Concept
|
Healthcare Financing
|
|
Concept
|
Microbiota
|
|
Concept
|
CCR5 Receptor Antagonists
|
|
Concept
|
Non-Randomized Controlled Trials as Topic
|
|
Concept
|
Datasets as Topic
|
|
Concept
|
RAW 264.7 Cells
|
|
Concept
|
Emtricitabine
|
|
Academic Article
|
Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.
|
|
Academic Article
|
SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues.
|
|
Academic Article
|
Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice.
|
|
Academic Article
|
Infectivity of Human Olfactory Neurons to SARS-CoV-2: A Link to Anosmia.
|
|
Academic Article
|
Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.
|
|
Academic Article
|
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
|
|
Academic Article
|
A click chemistry amplified nanopore assay for ultrasensitive quantification of HIV-1 p24 antigen in clinical samples.
|